Tak Wah Mak
About
Tak Wah Mak, OC OOnt FRS FRSC (Chinese: 麥德華; pinyin: Mài Déhuá; born October 4, 1946 in China) is a Canadian medical researcher, geneticist, oncologist, and biochemist. He first became widely known for his discovery of the T-cell receptor in 1983 and pioneering work in the genetics of immunology. In 1995, Mak published a landmark paper on the discovery of the function of the immune checkpoint protein CTLA-4, thus opening the path for immunotherapy/checkpoint inhibitors as a means of cancer treatment. Mak is also the founder of Agios Pharmaceuticals, whose lead compound, IDHIFA®, was approved by the FDA for acute myeloid leukemia in August 2017, becoming the first drug specifically targeting cancer metabolism to be used for cancer treatment. He has worked in a variety of areas including biochemistry, immunology, and cancer genetics.
Key details
| Born |
4 October 1946 (age 78) China
|
| Zodiac | Libra |
| Tags | Add tag |
Partner
Family members
Romantic interests
Friends & associates
Scholars
Missing information for Tak Wah Mak
- missing gender
- missing height
- missing hair color
- missing eye color
- missing ethnicity
- add profile photo
- add banner photo
- add photos to gallery
- missing current partner
Similar profiles
Activity
Top contributors today
Tags
Featured contributors
Couples by country
USA · UK · Canada · Australia · France · Germany · India · China · South Korea · Japan · Spain · MexicoCouples by decade
1900s · 1910s · 1920s · 1930s · 1940s · 1950s · 1960s · 1970s · 1980s · 1990s · 2000s · 2010s · 2020s
